-
1
-
-
37249063841
-
TNFα blockade in human diseases: An overview of efficacy and safety
-
DOI 10.1016/j.clim.2007.08.012, PII S1521661607013265
-
Lin, J., Ziring, D., and Desai, S. TNF-alpha blockade in human diseases: an overview of efficacy and safety. Clin. Immunol. 126:13-30, 2008. (Pubitemid 350266448)
-
(2008)
Clinical Immunology
, vol.126
, Issue.1
, pp. 13-30
-
-
Lin, J.1
Ziring, D.2
Desai, S.3
Kim, S.4
Wong, M.5
Korin, Y.6
Braun, J.7
Reed, E.8
Gjertson, D.9
Singh, R.R.10
-
2
-
-
77955167490
-
Anti-TNF-alpha treatment: A possible promoter in endogenous uveitis? observational report on six patients: Occurrence of uveitis following etanercept treatment
-
Kakkassery, V., Mergler, S., and Pleyer, U. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Curr. Eye Res. 35:751-756, 2010.
-
(2010)
Curr. Eye Res.
, vol.35
, pp. 751-756
-
-
Kakkassery, V.1
Mergler, S.2
Pleyer, U.3
-
3
-
-
77955007144
-
Treatment of primary Sjögren syndrome: A systematic review
-
Ramos-Casals, M., Tzioufas, A.G., and Stone, J.H. Treatment of primary Sjögren syndrome: a systematic review. JAMA 304:452-460, 2010.
-
(2010)
JAMA
, vol.304
, pp. 452-460
-
-
Ramos-Casals, M.1
Tzioufas, A.G.2
Stone, J.H.3
-
4
-
-
84883577100
-
The first decade of biologic TNF antagonists in clinical practice: Lessons learned, unresolved issues and future directions
-
Sfikakis, P.P. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr. Dir. Autoimmun. 11:180-210, 2010.
-
(2010)
Curr. Dir. Autoimmun.
, vol.11
, pp. 180-210
-
-
Sfikakis, P.P.1
-
5
-
-
77952800220
-
Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model
-
Johnsen-Soriano, S., Sancho-Tello, M., and Arnal, E. Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model. Ocul. Immunol. Inflamm. 18:208- 215, 2010.
-
(2010)
Ocul. Immunol. Inflamm.
, vol.18
, pp. 208-215
-
-
Johnsen-Soriano, S.1
Sancho-Tello, M.2
Arnal, E.3
-
6
-
-
79952951363
-
Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease
-
Sugita, S., Yamada, Y., and Mochizuki, M. Relationship between serum infliximab levels and acute uveitis attacks in patients with Behcet disease. Br. J. Ophthalmol. 95:549-552, 2011.
-
(2011)
Br. J. Ophthalmol.
, vol.95
, pp. 549-552
-
-
Sugita, S.1
Yamada, Y.2
Mochizuki, M.3
-
7
-
-
70549095941
-
Intravitreal infleximab in experimental endotoxin-induced uveitis
-
Hosseini, H., Safaei, A., Kalili, M., et al. Intravitreal infleximab in experimental endotoxin-induced uveitis. Eur. J. Ophthalmol. 19:818-823, 2009.
-
(2009)
Eur. J. Ophthalmol.
, vol.19
, pp. 818-823
-
-
Hosseini, H.1
Safaei, A.2
Kalili, M.3
-
8
-
-
64349100107
-
Intra vitreal administration of the anti- tumor necrosis factor agent infleximab for neovascular age-related macular degeneration
-
Theodossiadis, P.G., Liarakos, V.S., Sfikakis, P.P., et al. Intra vitreal administration of the anti- tumor necrosis factor agent infleximab for neovascular age-related macular degeneration. Am. J. Ophthalmol. 147:825-830, 2009
-
(2009)
Am. J. Ophthalmol.
, vol.147
, pp. 825-830
-
-
Theodossiadis, P.G.1
Liarakos, V.S.2
Sfikakis, P.P.3
-
9
-
-
77958586098
-
Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis
-
Farvardin, M., Afarid, M., and Mehryar, M. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis. Retina 30:1530-1535, 2010.
-
(2010)
Retina
, vol.30
, pp. 1530-1535
-
-
Farvardin, M.1
Afarid, M.2
Mehryar, M.3
-
10
-
-
75149190168
-
Adverse events after intravitreal infliximab (Remicade)
-
Giganti, M., Beer, P.M., and Lemanski, N. Adverse events after intravitreal infliximab (Remicade). Retina 30:71-80, 2010.
-
(2010)
Retina
, vol.30
, pp. 71-80
-
-
Giganti, M.1
Beer, P.M.2
Lemanski, N.3
-
11
-
-
79952270370
-
Induction of regulatory T cells by infliximab in Behcet's disease
-
Sugita, S., Yamada, Y., and Kaneko, S. Induction of regulatory T cells by infliximab in Behcet's disease. Invest. Ophthalmol. Vis. Sci. 52:476-484, 2011.
-
(2011)
Invest. Ophthalmol. Vis. Sci.
, vol.52
, pp. 476-484
-
-
Sugita, S.1
Yamada, Y.2
Kaneko, S.3
-
12
-
-
78649334362
-
Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions
-
Adán, A., Hernandez, V., and Ortiz, S. Effects of infliximab in the treatment of refractory posterior uveitis of Behçet's disease after withdrawal of infusions. Int. Ophthalmol. 30:577-581, 2010.
-
(2010)
Int. Ophthalmol.
, vol.30
, pp. 577-581
-
-
Adán, A.1
Hernandez, V.2
Ortiz, S.3
-
13
-
-
77949343136
-
Efficacy of infliximab on the acute attack of uveitis
-
Alokaily, F., Alsaleh, S., and Al-Balawi, M. Efficacy of infliximab on the acute attack of uveitis. Saudi Med. J. 31:82-85, 2010.
-
(2010)
Saudi Med. J.
, vol.31
, pp. 82-85
-
-
Alokaily, F.1
Alsaleh, S.2
Al-Balawi, M.3
-
14
-
-
23644447065
-
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: An open-label trial
-
DOI 10.1002/art.21231
-
Tugal-Tutkun, I., Mudun, A., and Urgancioglu, M. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial. Arthritis Rheum. 52:2478-2484, 2005. (Pubitemid 41117435)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.8
, pp. 2478-2484
-
-
Tugal-Tutkun, I.1
Mudun, A.2
Urgancioglu, M.3
Kamali, S.4
Kasapoglu, E.5
Inanc, M.6
Gul, A.7
-
15
-
-
84869470013
-
Development of experimental autoimmune uveitis: Efficient recruitment of monocytes is independent of CCR2
-
Dagkalis, A., Wallace, C., and Xu, H. Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2. Scand. J. Rheumatol. 38:58-62, 2009.
-
(2009)
Scand. J. Rheumatol.
, vol.38
, pp. 58-62
-
-
Dagkalis, A.1
Wallace, C.2
Xu, H.3
-
16
-
-
41949142753
-
A pilot study on ocular safety of intravitreal infleximab in a robbit model
-
Giansanti, F., Ramazzotti, M., Vannozzi, L., et al. A pilot study on ocular safety of intravitreal infleximab in a robbit model. Invest. Ophthalmol. Vis. Sci. 49:1151-1156, 2008.
-
(2008)
Invest. Ophthalmol. Vis. Sci.
, vol.49
, pp. 1151-1156
-
-
Giansanti, F.1
Ramazzotti, M.2
Vannozzi, L.3
-
17
-
-
84862863465
-
Adalimumab successful in Sarcoidosis patients with refractory chronic non-infectious uveitis
-
Erckens, R.J., Mostard, R.L., Wijnen, P.A., et al. Adalimumab successful in Sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 250:713-720, 2012.
-
(2012)
Graefes Arch. Clin. Exp. Ophthalmol.
, vol.250
, pp. 713-720
-
-
Erckens, R.J.1
Mostard, R.L.2
Wijnen, P.A.3
-
18
-
-
79551528030
-
Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: A pilot study from the Pan- American Collaborative Retina Study Group
-
Wu, L., Hernandez-Bogantes, E., Roca, J.A., et al. Intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan- American Collaborative Retina Study Group. Retina 31: 298-303, 2011.
-
(2011)
Retina
, vol.31
, pp. 298-303
-
-
Wu, L.1
Hernandez-Bogantes, E.2
Roca, J.A.3
|